Home › Funds › Qube Research & Technologies Ltd › GH
Qube Research & Technologies Ltd position in GH
GUARDANT HEALTH INC · Health Care
Qube Research & Technologies Ltd reported holding 1,306,069 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$233.0M, representing 0.46% of its reported portfolio and ranking #16 among its reported holdings. Qube Research & Technologies Ltd has disclosed GH holdings in 10 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Qube Research & Technologies Ltd's GH position evolved
Qube Research & Technologies Ltd first disclosed a stake in GH in Q4 2023 at 48,894 shares (US$1.3M). The position peaked in Q3 2026 at 1,306,069 shares, worth US$233.0M. Across 10 filings, Qube Research & Technologies Ltd increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,306,069 shares valued at US$233.0M — an increase of 1,149,833 shares quarter over quarter.. Notable position changes include a 163% increase in Q1 2024 (shares rose 40% over the following quarter), a 563% increase in Q4 2024 (shares rose 39% over the following quarter), a 736% increase in Q3 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 48.89K | $1.32M | New |
| Q1 2024 | 128.43K | $2.65M | Add |
| Q3 2024 | 60.13K | $1.38M | New |
| Q4 2024 | 398.39K | $12.17M | Add |
| Q1 2025 | 319.43K | $13.61M | Reduce |
| Q2 2025 | 254.20K | $13.23M | Reduce |
| Q3 2025 | 570.10K | $35.62M | Add |
| Q4 2025 | 67.12K | $6.86M | Reduce |
| Q2 2026 | 156.24K | $23.44M | New |
| Q3 2026 | 1.31M | $232.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GH and 13F data
GH (GUARDANT HEALTH INC) is a Health Care company. 57 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FEDERATED HERMES, INC. (US$445.6M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GH
- Deep Track Capital, LP 3.39M sh · $509.10M · Q2 2026
- FEDERATED HERMES, INC. 2.50M sh · $445.59M · Q3 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 2.63M sh · $394.43M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.96M sh · $293.79M · Q2 2026
- TWO SIGMA ADVISERS, LP 2.38M sh · $243.33M · Q4 2025
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.34M sh · $239.23M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $230.14M · Q2 2026
- RTW INVESTMENTS, LP 1.48M sh · $222.20M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 72.78M sh · $213.01M · Q3 2026
- Hood River Capital Management LLC 1.40M sh · $209.34M · Q2 2026
- AGF MANAGEMENT LTD 1.13M sh · $201.82M · Q3 2026
- Aequim Alternative Investments LP 65.00M sh · $190.66M · Q3 2026
More on Qube Research & Technologies Ltd
FAQ
How long has Qube Research & Technologies Ltd held GH?
Qube Research & Technologies Ltd has disclosed GH holdings in 10 of the last 12 reported quarters, going back to Q4 2023.
What is Qube Research & Technologies Ltd's current position in GH?
As of Q3 2026, Qube Research & Technologies Ltd holds 1.31M shares of GH (GUARDANT HEALTH INC), valued at $232.95M, representing 0.46% of its reported portfolio and ranking #16.
Has Qube Research & Technologies Ltd been buying or selling GH?
In the latest 13F filing (Q3 2026), Qube Research & Technologies Ltd increased its position in GH. The position peaked in Q3 2026 at 1.31M shares.
Which other funds hold GH?
Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., FULLER & THALER ASSET MANAGEMENT, INC., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.